Publications by authors named "Miranda Lee"

Claim this Profile
H
Habituation for professional learning: a qualitative study of physiotherapy students' experiences working with anatomy cadavers.
Rebecca Bergen, Emily Lowry, Luke Gregg, Heejin Kim, Miranda Lee

Physiother Theory Pract· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participant and caregiver perspectives on health feedback from a healthy lifestyle check.
Miranda D Lee, Cervantée E K Wild, Ken J Taiapa, Ngauru T Rawiri, Victoria Egli

Health Expect· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyrotropin Receptor Antagonism by a Novel Small Molecule: Preclinical Observations.
George J Kahaly, Lisa Steiner, Miranda M C van der Lee, Tanja A E van Achterberg, Roel J Arends

Thyroid· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody-Drug Conjugate.
Patrick G Groothuis, Daniëlle C H Jacobs, Inge A T Hermens, Désirée Damming, Kim Berentsen, Miranda M C van der Lee

Mol Cancer Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of SYD5115, a novel orally active small molecule TSH-R antagonist.
Willem F J Karstens, Wiro M B P Menge, Gijs Martens, Sanne J N Op Het Veld, Jacobus Th H van Eupen, Miranda M C van der Lee

Bioorg Med Chem· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells.
Mary J van Helden, Seline A Zwarthoff, Roel J Arends, Inge M J Reinieren-Beeren, Marc C B C Paradé, Miranda M C van der Lee

J Immunother Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State Department and Provider Agency Utilization of Evidence-Based Program Registries in Behavioral Healthcare and Child Welfare.
Stephen Magura, Miranda J Lee, Ruqayyah N Abu-Obaid, John Landsverk, Whitney DeCamp

Eval Health Prof· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
References to Evidence-based Program Registry (EBPR) websites for behavioral health in U.S. state government statutes and regulations.
Miranda J Lee, Michael J Maranda, Stephen Magura, Gregory Greenman

J Appl Soc Sci (Boulder)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State behavioral health agency website references to evidence-based program registers.
Michael J Maranda, Stephen Magura, Ryan Gugerty, Miranda J Lee, John A Landsverk

Eval Program Plann· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Platform for the Generation of Site-Specific Antibody-Drug Conjugates That Allows for Selective Reduction of Engineered Cysteines.
Ruud G E Coumans, Gerry J A Ariaans, Henri J Spijker, Pascal Renart Verkerk, Patrick H Beusker, Miranda M C van der Lee

Bioconjug Chem· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice.
Ruud Ubink, Eef H C Dirksen, Myrthe Rouwette, Ebo S Bos, Ingrid Janssen, Miranda M C van der Lee

Mol Cancer Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Isoform-Specific Gating Kinetics of hERG1 Channel: Combined Experimental and Simulation Study.
Laura L Perissinotti, Pablo M De Biase, Jiqing Guo, Pei-Chi Yang, Miranda C Lee, Colleen E Clancy

Front Physiol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single cell transcriptome profiling of developing chick retinal cells.
Lauren A Laboissonniere, Gregory M Martin, Jillian J Goetz, Ran Bi, Brock Pope, Miranda Lee

J Comp Neurol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.
Gerard Ja Rouwendal, Miranda M van der Lee, Saskia Meyer, Karli R Reiding, Jan Schouten

MAbs· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression.
Jonathan Black, Gulden Menderes, Stefania Bellone, Carlton L Schwab, Elena Bonazzoli, Miranda M C van der Lee

Mol Cancer Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody-Drug Conjugate SYD985.
Ronald C Elgersma, Ruud G E Coumans, Tijl Huijbregts, Wiro M P B Menge, John A F Joosten, Miranda M C van der Lee

Mol Pharm· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers.
Miranda M C van der Lee, Patrick G Groothuis, Ruud Ubink, Monique A J van der Vleuten, Tanja A van Achterberg

Mol Cancer Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical profile of the HER2-targeting ADC SYD983/SYD985: introduction of a new duocarmycin-based linker-drug platform.
Wim Dokter, Ruud Ubink, Miranda van der Lee, Monique van der Vleuten, Tanja van Achterberg

Mol Cancer Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine cooperativity is caused by competitive glycosaminoglycan binding.
Folkert Verkaar, Jody van Offenbeek, Miranda M C van der Lee, Lambertus H C J van Lith, Anne O Watts

J Immunol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
Anne O Watts, Folkert Verkaar, Miranda M C van der Lee, Claudia A W Timmerman, Martien Kuijer

J Biol Chem· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
Miranda M C van der Lee, Folkert Verkaar, Jesse W Y Wat, Jody van Offenbeek, Martijn Timmerman

Cell Signal· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1.
Miranda M C van der Lee, Marion Blomenröhr, Antoon A van der Doelen, Jesse W Y Wat, Niels Smits

J Biomol Screen· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptor.
Petra de Kruijf, Jane van Heteren, Herman D Lim, Paolo G M Conti, Miranda M C van der Lee

J Pharmacol Exp Ther· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
Miranda M C van Der Lee, Maaike Bras, Chris J van Koppen, Guido J R Zaman

J Biomol Screen· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme fragment complementation binding assay for p38alpha mitogen-activated protein kinase to study the binding kinetics of enzyme inhibitors.
Guido J R Zaman, Miranda M C van der Lee, Jacobus J Kok, Rob L H Nelissen, Elma E M G Loomans

Assay Drug Dev Technol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis